advanced and versatile PRInting platform
for the next generation of active Microfluidic dEvices
To get a better idea of what PRIME is, which partners are working together
and what our goals are, please watch this video.
PRIME was featured in the latest BNN QUARTERLY issue on "Biofunctionalization" in September 2023 with the article "PRIME: Bringing Light to Microfluidics" (pages 35-39) Download QUARTERLY & enjoy reading!
On 14 September 2023, PRIME held its final dissemination event, “Microfluidics in their PRIME: Microfluidic Chips, Active Valves, Smart Sensors, and What Comes Next” at TUtheSky in Vienna, where the consortium presented their results alongside others in the field of...
In June 2023, PRIME was featured in the Microfluidics special issue of the Botenstoff, the digital magazine of Human.technology Styria GmbH. Human.technology Styria is a cluster of roughly 140 organizations and businesses located in the Austrian provice of Styria...
Follow us on Social Media!
About the Project
Microfluidic devices manipulate tiny amounts of fluid enabling cost-effective, fast, accurate and high throughput analytical assays. Progress in Microfluidics has huge impact in environmental pollution monitoring, biohazard detection and biomedicine, contributing to the development of new tools for drug screening, biological studies, point-of-care diagnostics and personalized medicine.
PRIME aims to go beyond the state-of-the-art generating a robust platform to create a new generation of active, tubeless and contactless microfluidic chips effectively changing the currently established paradigm.